Abstract

Valproic acid (VPA) is an antiepileptic drug that has been used for various indications. VPA intoxication is frequent because of its narrow therapeutic range and widespread prescription for different clinical situations. We reported a pediatric VPA intoxication case who was treated with hemodialysis. A 14-year-old previously healthy girl was admitted to the pediatric intensive care unit three hours after ingestion of 15 tablets of controlled release VPA (7500 mg) VPA ingestion for suicidal attempt. She was lethargic while other physical examination findings were normal. Serum VPA level was 347.8 μg/mL on admission. Blood gas analysis revealed high anion gap metabolic acidosis and elevation of lactate. Because of metabolic acidosis is indicating poor prognosis, hemodialysis was performed. After four hours of hemodialysis her consciousness was improved and serum VPA level decreased and blood gas analysis revealed normal pH and lactate level. After the first hemodialysis session, the serum VPA level continued to decrease and there was no abnormality on blood gas analysis during follow-up. She was discharged on the third day of her hospitalization. Hemodialysis treatment is effective in VPA intoxication because it removes the drug and treats the acidosis. In this case report, it is shown that in case of high amount of VPA ingestion especially controlled release drug and early initiation of metabolic acidosis, performing hemodialysis before the organ failure symptoms would be protective for further organ failure development.

Keywords: Child, Hemodialysis, Valproic acid, Intoxication

References

  1. Sztajnkrycer MD. Valproic acid toxicity: Overview and management. J Toxicol Clin Toxicol 2002;40:789-801.
  2. Al Aly Z, Yalamanchili P, Gonzalez E. Extracorporeal management of valproic acid toxicity: A case report and review of the literature. Semin Dial 2005;18:62-6.
  3. Doyon S. Anticonvulsants. In: Goldfrank LR, Howland MA, Flomenbaum NE (eds). Goldfrank’s Toxicologic Emergencies. 9th ed. New York, NY: McGraw Hill, 2011:47-705,706.
  4. Sikma MA, Mier JC, Meulenbelt J. Massive valproic acid overdose, a misleading case. Am J Emerg Med 2008;26:110.e3-6
  5. Spiller HA, Krenzelok EP, Klein-Schwartz W, Winter ML, Weber JA, Sollee DR, et al. Multicenter case series of valproic acid ingestion. J Toxicol Clin Toxicol 2000;38:755-60.
  6. Farrar HC, Herold DA, Reed MD. Acute valproic acid intoxication: Enhanced drug clearance with oral-activated charcoal. Crit Care Med 1993;21:299-301.
  7. Ishikura H, Matsuo N, Matsubara M, Ishihara T, Takeyama N, Tanaka T. Valproic acid overdose and L-carnitine therapy. J Anal Toxicol 1996;20:55-8.
  8. Arslanköylü AE, Alakaya M, Akyılmaz E, Çelik Y, Delibaş A. Severe valproic acid intoxication responding to hemodialysis. J Pediatr Emerg Intensive Care Med 2017;4:77-9.
  9. Jung J, Eo E, Ahn KO. A case of hemoperfusion and l-carnitine management in valproic acid overdose. Am J Emerg Med 2008;26:388.e3,4.
  10. Temel V, Arikan M, Temel G. High-flux hemodialysis and levocarnitine in the treatment of severe valproic Acid intoxication. Case Rep Emerg Med 2013;2013:526469.
  11. Ghannoum M, Laliberte M, Nolin TD, Mactier R, Lavergne V, Hoffman RS, et al. Extracorporeal treatment for valproic acid poisoning: Systematic review and recommendations from the EXTRIP work group. Clin Toxicol (Phila) 2015;53:454-65.

How to cite

1.
Kılıç AO. The Successful Treatment of Pediatric Valproic Acid Intoxication with Hemodialysis. Turk J Pediatr Dis [Internet]. 2019 Jul. 30 [cited 2025 Sep. 22];13(4):306-9. Available from: https://turkjpediatrdis.org/article/view/598